nabCapital CEO presents Science in Business Award

30 November

nabCapital CEO John Hooper, this week, presented the 2008 Science in Business Awards for research commercialisation projects which included an emerging vaccine technology developed by veski innovation fellow Dr Gareth Forde.

At a presentation event on Wednesday, 26 November 2008, hosted by Dr Alan Finkel, Chancellor of Monash University, Chief Executive Officer - nabCapital Mr John Hooper presented the nabCapital Science in Business Awards to the winning students from the Monash University Master of Business (Commercialising Science & Technology) 2008 class.

veski innovation fellow Dr Gareth Fordes' emerging vaccine technology: Efficient production of plasmid DNA vaccines -An invention, currently being reviewed by a number of international companies, provides a means of rapidly and efficiently producing large quantities of plasmid DNA vaccines, with potential for vaccination against pandemics and diseases such as malaria. It is already being used in the development of an experimental malaria vaccine at Monash.

What's On

April

S M T W T F S
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
 
 

veski fellows in the news

Feb 2020 | Peter MacCallum Cancer Centre

Prof Mark Dawson - Australia-First Winner of Global Haematology Award

Jan 2020 | Nature MucosalImmunology

#1 most read paper of 2019 - Prof Ben Marsland's Nature MucosalImmunology publication.

 

“The real benefit of increasing fabrication rates is the transition from prototyping, making one offs, to actually going into production.”

Assoc Prof Timothy Scott

Tweets from @veskiorg